These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3491421)

  • 61. Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation.
    Teunissen MB; Rongen HA; Bos JD
    J Immunol; 1994 Apr; 152(7):3400-9. PubMed ID: 7511646
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antigen-presenting capacity in patients with sarcoidosis.
    Ina Y; Takada K; Yamamoto M; Morishita M; Miyachi A
    Chest; 1990 Oct; 98(4):911-6. PubMed ID: 2119953
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rheumatoid synovial dendritic cells as stimulators in allogeneic and autologous mixed leukocyte reactions--comparison with autologous monocytes as stimulator cells.
    Waalen K; Thoen J; Førre O; Hovig T; Teigland J; Natvig JB
    Scand J Immunol; 1986 Feb; 23(2):233-41. PubMed ID: 2937138
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Response of human T lymphocytes to phytohemagglutinin (PHA) after sequential depletion of monocytes, HLA-DR+, Leu11a+, and Leu7+ cells.
    Ulmer AJ; Scholz W; Ernst M; Flad HD
    Immunobiology; 1985 Dec; 170(5):419-33. PubMed ID: 2936677
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of HLA-DR antigens in PPD-stimulated lymphocyte-monocyte interactions.
    Haar D; Heron I
    Scand J Immunol; 1982 Nov; 16(5):403-11. PubMed ID: 6184773
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Purified human oral mucosal Langerhans cells function as accessory cells in vitro.
    Barrett AW; Ross DA; Goodacre JA
    Clin Exp Immunol; 1993 Apr; 92(1):158-63. PubMed ID: 7682163
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Accessory cells, dendritic cells, or monocytes, are required for the lymphokine-activated killer cell induction from resting T cell but not from natural killer cell precursors.
    Silvennoinen O; Vakkila J; Hurme M
    J Immunol; 1988 Aug; 141(4):1404-9. PubMed ID: 3260925
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Depressed PPD and tetanus toxoid presentation by monocytes to T lymphocytes in patients with rheumatoid arthritis: restoration by interferon gamma.
    Seitz M; Napierski I; Kirchner H
    Rheumatol Int; 1988; 8(5):189-96. PubMed ID: 3148994
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression and function of B7 on human epidermal Langerhans cells.
    Symington FW; Brady W; Linsley PS
    J Immunol; 1993 Feb; 150(4):1286-95. PubMed ID: 7679425
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Characterization of PPD-specific T-cell lines generated in type I (insulin-dependent) diabetic and healthy individuals.
    Mølvig J; Sønderstrup McDevitt G; Thomsen M; Bosmann B; Blangero C; de Preval C; Baek L; Nerup J
    Scand J Immunol; 1989 Nov; 30(5):615-29. PubMed ID: 2587937
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes.
    Tjernlund U; Scheynius A
    Scand J Immunol; 1987 Jul; 26(1):1-6. PubMed ID: 2441455
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin.
    Hasséus B; Jontell M; Bergenholtz G; Dahlgren UI
    Clin Exp Immunol; 2004 Jun; 136(3):483-9. PubMed ID: 15147350
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of human monocyte antigen presentation, but not HLA-DR expression, by cyclosporine.
    Snyder DS; Wright CL; Ting C
    Transplantation; 1987 Sep; 44(3):407-11. PubMed ID: 3114926
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
    de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
    J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Activation of alloreactive T cells by allogeneic nonprofessional antigen-presenting cells and interleukin-12 from bystander autologous professional antigen-presenting cells.
    de Haan A; van der Gun I; van Dijk E; Hepkema BG; Prop J; de Leij LF
    Transplantation; 2000 Apr; 69(8):1637-44. PubMed ID: 10836375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis.
    Fujiwara H; Kleinhenz ME; Wallis RS; Ellner JJ
    Am Rev Respir Dis; 1986 Jan; 133(1):73-7. PubMed ID: 2935057
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.
    Waalen K; Førre O; Teigland J; Natvig JB
    Clin Exp Immunol; 1987 Oct; 70(1):1-9. PubMed ID: 2826055
    [TBL] [Abstract][Full Text] [Related]  

  • 79. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells.
    Demidem A; Taylor JR; Grammer SF; Streilein JW
    J Invest Dermatol; 1991 Sep; 97(3):454-60. PubMed ID: 1875046
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
    Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.